Please ensure Javascript is enabled for purposes of website accessibility

5 of Last Week's Biggest Losers

By Rick Munarriz – Jan 27, 2013 at 6:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The five stocks posted double-digit declines over the past week.

There's never a shortage of losers in the stock market. Let's take a closer look at five of this past week's biggest sinkers.


Jan. 25

Weekly Loss

My Watchlist

IAMGOLD (IAG -10.62%)




Neutral Tandem (IQNT)




Apple (AAPL -1.51%)




Arena Pharmaceuticals (ARNA)




Coeur d'Alene Mines (CDE -7.33%)




Source: Barron's.

Investors rotated out of gold mining stocks last week. Several miners suffered double-digit dips, but IAMGOLD led the way lower with its 24% drop.

The gold and niobium miner didn't do itself any favors by sticking to its production guidance for 2013 but warning of a healthy spike in production costs.

Neutral Tandem was a victim of a reshuffling of the S&P Dow Jones Indices' lineups, as the stock was booted from the S&P SmallCap 600 after its low market cap -- now below $100 million -- made it no longer representative of the small-cap realm.

Apple's nightmare continues. The consumer tech giant stumbled after posting disappointing quarterly results. Apple was excited to sell more than 75 million iOS devices, but they're not as profitable as they used to be. Gross and net margins were squeezed, and that may not get better in the near future as Apple has to sacrifice margins to maintain market share.

Arena Pharmaceuticals shed some weight after European regulators asked for more information on its obesity drug. This isn't necessarily a deal-breaker, though it doesn't bode well for Belviq's chances for approval in Europe.

Coeur d'Alene Mines stumbled after kicking off the week with a BMO Capital Markets downgrade. It then went on to take on more debt by offering $200 million in senior notes.

Longtime Fool contributor Rick Aristotle Munarriz has no position in any stocks mentioned. The Motley Fool recommends and owns shares of Apple. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Apple Inc. Stock Quote
Apple Inc.
$150.43 (-1.51%) $-2.31
Arena Pharmaceuticals, Inc. Stock Quote
Arena Pharmaceuticals, Inc.
IAMGOLD Corporation Stock Quote
IAMGOLD Corporation
$1.01 (-10.62%) $0.12
Coeur Mining, Inc. Stock Quote
Coeur Mining, Inc.
$2.78 (-7.33%) $0.22
Inteliquent, Inc. Stock Quote
Inteliquent, Inc.

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.